logo

James Doroshow, MD

James Doroshow, MD

Oncology Bethesda, MD

Physician

Office Address

Office Map
  • 3a44 Bidg 31
    31 Center Drive
    Bethesda, MD 20892
    Phone: (301) 496-4291

Summary

  • Dr. James Doroshow, MD is a board certified oncologist in Bethesda, Maryland. He is currently licensed to practice medicine in California. He is affiliated with National Insts of Health.

Dr. Doroshow's Clinical Specialties & Interests

  • Oncology: General Oncology

Dr. Doroshow's Education & Medical Training

  • Massachusetts General HospitalMassachusetts General HospitalResidency, Internal Medicine
  • Harvard Med SchHarvard Medical SchoolMedical School

Dr. Doroshow's Certifications & Licensure

  • CA State Medical LicenseCA State Medical License1975 - 2014
  • American Board of Internal MedicineAmerican Board of Internal MedicineInternal Medicine
  • American Board of Internal MedicineAmerican Board of Internal MedicineMedical Oncology

Dr. Doroshow's Awards, Honors, & Recognition

  • Marquis Whos WhoWhos Who in Medicine and HealthcareMarquis Whos Who

Dr. Doroshow's Publications & Presentations

PubMed | Citations by Web of Science®

Grant Support

  • Roles Of Nadph Oxidase 5 And Dual Oxidase 2 In Cancer
    Roles Of Nadph Oxidase 5 And Dual Oxidase 2 In CancerNational Cancer Institute
    2010 - 2011
  • Phase 01 Clinical Trials
    Phase 01 Clinical TrialsNational Cancer Institute
    2010 - 2011
  • Nadph Oxidase 1: A Novel Target For Colon Cancer Therapy
    Nadph Oxidase 1: A Novel Target For Colon Cancer TherapyNational Cancer Institute
    2010 - 2011
  • Roles Of Nadph Oxidase 5 And Dual Oxidase 2 In Cancer
    Roles Of Nadph Oxidase 5 And Dual Oxidase 2 In CancerDivision Of Basic Sciences - Nci
    2009 - 2009
  • Phase 01 Clinical Trials
    Phase 01 Clinical TrialsDivision Of Basic Sciences - Nci
    2009 - 2009
  • Nadph Oxidase 1: A Novel Target For Colon Cancer Therapy
    Nadph Oxidase 1: A Novel Target For Colon Cancer TherapyDivision Of Basic Sciences - Nci
    2009 - 2009
  • Phase 01 Clinical Trials
    Phase 01 Clinical TrialsNational Cancer Institute
    2008 - 2008
  • Nadph Oxidase 1: A Novel Target For Colon Cancer Therapy
    Nadph Oxidase 1: A Novel Target For Colon Cancer TherapyNational Cancer Institute
    2007 - 2008
  • Nadph Oxidase 1: A Novel Target For Colon Cancer Therapy
    Nadph Oxidase 1: A Novel Target For Colon Cancer TherapyDivision Of Basic Sciences - Nci
    2005 - 2006
  • Phi-39: Phase I Trial Of #7389 (Halichondrin B Analog)
    Phi-39: Phase I Trial Of #7389 (Halichondrin B Analog)National Center For Research Resources
    2004 - 2004
  • A Phase I Pharmacokinetic Study Of STI-571 In Patients
    A Phase I Pharmacokinetic Study Of STI-571 In PatientsNational Center For Research Resources
    2004 - 2004
  • Oncology Research Career Development Program
    Oncology Research Career Development ProgramNational Cancer Institute
    2003 - 2003
  • MDR1 Gene Therapy In CD34+ Cells And SCID Mice
    MDR1 Gene Therapy In CD34+ Cells And SCID MiceNational Cancer Institute
    2002 - 2002
  • Clinical Oncology Research Career Development Program
    Clinical Oncology Research Career Development ProgramNational Cancer Institute
    1999 - 2002
  • Phase I Molecular And Clinical Pharmacodynamic Trials
    Phase I Molecular And Clinical Pharmacodynamic TrialsNational Cancer Institute
    1999 - 2003
  • CITY Of HOPE Southwest Group Clinical Trials
    CITY Of HOPE Southwest Group Clinical TrialsNational Cancer Institute
    1999 - 2004
  • National Cancer Institute Initial Review Group
    National Cancer Institute Initial Review GroupNational Cancer Institute
    1999 - 2000
  • CITY Of HOPE Southwest Group Clinical Trials
    CITY Of HOPE Southwest Group Clinical TrialsNational Cancer Institute
    1998 - 1998
  • Phase I Molecular And Clinical Pharmacodynamic Trials
    Phase I Molecular And Clinical Pharmacodynamic TrialsNational Cancer Institute
    1998 - 1998
  • Pharmacodynamic Phase II Breast, Lung And Ovary Trials
    Pharmacodynamic Phase II Breast, Lung And Ovary TrialsNational Cancer Institute
    1997 - 2001
  • Clinical Oncology Research Career Development Program
    Clinical Oncology Research Career Development ProgramNational Cancer Institute
    1997 - 1998
  • Molecular Breast Cancer Therapy And Carcinogenesis
    Molecular Breast Cancer Therapy And CarcinogenesisNational Cancer Institute
    1994 - 1994
  • Molecular Breast Cancer Therapy And Carcinogenesis
    Molecular Breast Cancer Therapy And CarcinogenesisNational Cancer Institute
    1994 - 1997
  • Pharmacodynamic Phase II Breast, Lung And Ovary Trials
    Pharmacodynamic Phase II Breast, Lung And Ovary TrialsNational Cancer Institute
    1994 - 1996
  • Clinical Oncology
    Clinical OncologyNational Cancer Institute
    1994 - 1996
  • Southwest Oncology Group--Clinical Trials
    Southwest Oncology Group--Clinical TrialsNational Cancer Institute
    1993 - 1997
  • Coh Clinical Oncology Research Development Program
    Coh Clinical Oncology Research Development ProgramNational Cancer Institute
    1992 - 1993
  • Coh Southwest Oncology  Group Clinical Trials
    Coh Southwest Oncology Group Clinical TrialsNational Cancer Institute
    1988 - 1992
  • Cancer Center Support Grant
    Cancer Center Support GrantNational Cancer Institute
    1987 - 1990
  • Oxygen Radicals And Anticancer Quinones
    Oxygen Radicals And Anticancer QuinonesNational Cancer Institute
    1985 - 1986

Dr. Doroshow's Professional Memberships

Hospital Affiliations

Alternate Names

  • Dr. James Doroshow, Dr. James Doroshow, MD, Dr. J Doroshow, Dr. James H Doroshow

18 Colleague Invites!
Is this you? If so, register to see 18 messages.

Physicians, view Dr. Doroshow's full Doximity profile to:

  • Trade HIPAA-secure messages
  • Send and receive online faxes
  • Refer a patient
  • See their complete CV